Literature DB >> 12234996

The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.

Lin Lin1, Charles T Miller, Jorge I Contreras, Michael S Prescott, Susan L Dagenais, Rong Wu, John Yee, Mark B Orringer, David E Misek, Samir M Hanash, Thomas W Glover, David G Beer.   

Abstract

Genomic amplification is observed in many, if not all, types of human malignancy and is one of the mechanisms for the activation of dominant-acting oncogenes in tumorigenesis. In the present study, three amplified restriction fragments were identified in an esophageal adenocarcinoma (P16) using the restriction landmark genome scanning two-dimensional gel technique. These fragments were cloned, sequenced, and mapped to chromosome band 14q13. Using the sequence tagged site-amplification mapping approach, we defined the core-amplified domain by screening 75 normal-tumor paired esophageal samples. The frequency of 14q13 amplification is 6.7% in esophageal tumors, and the amplicon spans >6 Mb in 1 tumor but is contained in a region <0.3 Mb in all of the remaining amplified tumors. Quantitative reverse transcription-PCR (RT-PCR) of 8 genes and expressed sequence tags located within the core-amplified domain revealed that the HNF3alpha (FOXA1)(4) gene, a forkhead gene family member, was overexpressed in all of the amplified esophageal tumors. HNF3alpha amplification was confirmed by Southern blot and interphase fluorescence in situ hybridization analyses, and the results of real-time RT-PCR were consistent with that of the regular quantitative RT-PCR. Increased immunohistochemical nuclear staining of the HNF3alpha protein was detected in all of the tumors containing 14q13 amplification. Affymetrix oligonucleotide microarrays of 86 lung adenocarcinomas demonstrated that expression of the HNF3alpha mRNA was elevated (> or =2.5-fold of mean expression in normal lung) in 37% (32 of 86) of the tumors analyzed. Gene amplification of HNF3alpha was detected in 2 of the 5 overexpressed lung tumors examined. This is the first report of HNF3alpha amplification, and overexpression in esophageal and lung adenocarcinomas. Amplification of HNF3alpha in esophageal and lung tumors may suggest a potential oncogenic role for this gene in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234996

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  57 in total

Review 1.  FOXA1: master of steroid receptor function in cancer.

Authors:  Michael A Augello; Theresa E Hickey; Karen E Knudsen
Journal:  EMBO J       Date:  2011-09-20       Impact factor: 11.598

2.  FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription.

Authors:  Mathieu Lupien; Jérôme Eeckhoute; Clifford A Meyer; Qianben Wang; Yong Zhang; Wei Li; Jason S Carroll; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2008-03-21       Impact factor: 41.582

3.  MicroRNA-30a-5p suppresses proliferation, invasion and tumor growth of hepatocellular cancer cells via targeting FOXA1.

Authors:  Shuliang Zhang; Qin Liu; Qi Zhang; Ling Liu
Journal:  Oncol Lett       Date:  2017-08-10       Impact factor: 2.967

Review 4.  Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes.

Authors:  S W Davis; F Castinetti; L R Carvalho; B S Ellsworth; M A Potok; R H Lyons; M L Brinkmeier; L T Raetzman; P Carninci; A H Mortensen; Y Hayashizaki; I J P Arnhold; B B Mendonça; T Brue; S A Camper
Journal:  Mol Cell Endocrinol       Date:  2009-12-16       Impact factor: 4.102

5.  Targeted imaging of esophageal neoplasia with a fluorescently labeled peptide: first-in-human results.

Authors:  Matthew B Sturm; Bishnu P Joshi; Shaoying Lu; Cyrus Piraka; Supang Khondee; Badih Joseph Elmunzer; Richard S Kwon; David G Beer; Henry D Appelman; Danielle Kim Turgeon; Thomas D Wang
Journal:  Sci Transl Med       Date:  2013-05-08       Impact factor: 17.956

6.  Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinoma.

Authors:  Lin Lin; Adam J Bass; William W Lockwood; Zhuwen Wang; Amy L Silvers; Dafydd G Thomas; Andrew C Chang; Jules Lin; Mark B Orringer; Weiquan Li; Thomas W Glover; Thomas J Giordano; Wan L Lam; Matthew Meyerson; David G Beer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-28       Impact factor: 11.205

Review 7.  Molecular mechanisms of Barrett's esophagus.

Authors:  Hao Chen; Yu Fang; Whitney Tevebaugh; Roy C Orlando; Nicholas J Shaheen; Xiaoxin Chen
Journal:  Dig Dis Sci       Date:  2011-10-08       Impact factor: 3.199

8.  Association of FOXA1 and EMT markers (Twist1 and E-cadherin) in breast cancer.

Authors:  Dorra BenAyed-Guerfali; Emna Dabbèche-Bouricha; Wajdi Ayadi; Fatma Trifa; Slim Charfi; Abdelmajid Khabir; Tahia Sellami-Boudawara; Raja Mokdad-Gargouri
Journal:  Mol Biol Rep       Date:  2019-04-02       Impact factor: 2.316

9.  Clinical significance and prognostic value of Forkhead box A1 expression in human epithelial ovarian cancer.

Authors:  Kai Wang; Chenan Guan; Chenyan Fang; Xiaoxiao Jin; Junhui Yu; Yuquan Zhang; Lingzhi Zheng
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

10.  Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.

Authors:  Arusha Oloumi; Mykola Maidan; Frances E Lock; Howard Tearle; Steven McKinney; William J Muller; Samuel A J R Aparicio; Shoukat Dedhar
Journal:  Breast Cancer Res       Date:  2010-06-21       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.